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EVIDENCE BASED NEURO-ONCOLOGY
Use of ultrasonic aspirator for CNS tumour resection
Noman Ahmad, Saqib Kamran Bakhshi, Muhammad Shahzad Shamim

Abstract
Ultrasonic aspirator (UA), or the Cavitron Ultrasonic
Aspirator (CUSA) as it is commonly referred to, utilizes
ultrasonic waves of variable range of frequencies to
disintegrate and excise tumours. It is developed as a
substitute of bipolar diathermy; a tool commonly
employed for coagulation that uses focussed electric
current and may damage tissues by virtue of contact, or
by the heat that it produces. Over the last 30 years, CUSA
has become increasingly popular in several soft tissue
surgeries, especially brain and spine tumour resection, as
it allows reduction in the use of bipolar diathermy. It is
assumed that CUSA improves both surgical safety and
clinical outcomes, and also reduces surgical time. Herein
the authors have reviewed the available literature on the
advantages of CUSA.
Keywords: Ultrasonic aspirator, CUSA, Brain tumour,
Spinal cord tumour.

Introduction
Ultrasonic aspirator (UA) is a useful piece of equipment
for surgeries on soft tissues, especially brain and spine
tumour resection. It is even considered essential in
certain cases. UA employs high frequency ultrasound
waves for fragmentation of the tumour tissue, which it
then aspirates. It is claimed that it allows a surgeon to
perform safe and fast debulking of tumours with
minimal risk to surrounding structures.1 Neural tissue
and blood vessels are also relatively protected during
dissection, reducing surgical time and intra-operative
blood loss, thereby improving surgical efficiency and
patient outcomes.2-5 By virtue of its design, as compared
to conventional methods of tumour removal using
bipolars, suction and forceps; Cavitron Ultrasonic
Aspirator (CUSA), a commonly used brand of UA, allows
surgeons to remove tumours without causing much
traction or manipulation.3 It also allows users to irrigate
the operative field that improves visibility and tissue
identification. Whereas older models were bulky and
difficult to use, newer models are not only better
designed, but also allow additional functions.
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Currently, UA is being employed in endoscopic as well as
open neurosurgery for resection of brain and spinal cord
tumours.6-8 In this review, we have summarized the
existing literature on the use of CUSA in neurosurgical
procedures.

Review of Evidence
In one of the earliest studies that assessed the role of
CUSA, Fasano et al., had reported their experience of
using UA in 52 brain tumour resections, including both
intra-axial and extra-axial lesions.8 They found several
advantages of UA compared to conventional surgical
techniques such as provision of good visibility of the
operative field, better removal of abnormal tissue,
sparing of major vessels with haemostatic effect on
vessels less than 1mm diameter and negligible brain
tissue manipulation, traction and thermal effects on
adjacent tissue.8 Soon after, Fred Epstein published a
detailed description on the use of CUSA for different
brain tumours, he recommended that with the use of
UA, the tumour can be debulked from the centre which
makes it easier to dissect the capsule from adjacent
neural structures and achieve gross total resection.9
Since then, UA has been used in the treatment of various
neoplasms including meningiomas, gliomas and
posterior fossa tumours. Tang et al., published their
experience with CUSA Excel, an advanced variant of the
UA, in 10 patients with anterior and middle skull-base
meningiomas. They had achieved complete tumour
resection in all the cases in their series, and
recommended routine use of CUSA in all meningioma
cases as it helped in avoiding damage to the
neurovascular structures.10
More recently, several authors have published their
experience with UA in endoscopic surgeries, both for
skull base and intraventricular tumours. Ledderose et al.,
reported their experience with Sonopet UA, another
brand of UA, for the management of anterior skull base
tumours through trans-nasal approach, in a feasibility
trial conducted on 10 patients. They found it to be useful
especially for highly vascularised tumours, by reducing
surgical complications and thereby improving
outcomes, but also encountered difficulty in reaching
tumours away from the midline via trans-nasal route due
to non-flexible tip of the UA.11 Similar results were
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reported by Oertel et al., where 3 patients with
obstructive hydrocephalus and 2 patients with pituitary
macroadenoma were treated using UA coupled with
neuroendoscope, and the lesions were removed without
significant complications.12 Cinalli et al., reported their
experience with UA in endoscopic management of
intraventricular, paraventricular and suprasellar tumours
in 12 paediatric patients, and reported good outcomes,
with gross total or near total resection in up to half of
their patients. 13 Although some earlier reports on
endoscope coupled UA, had reported temporary loss of
visibility due to air bubbles, Cinalli et al. did not
encounter this problem.13,14 Apart from the surgical
benefits of using UA, some authors have also reported
diagnostic advantages of using UA. In a retrospective
study, Rao et al., analysed 73 CNS tumour samples
obtained via CUSA, and compared the findings with
those on samples obtained via conventional methods.
They recommended that tumour sample collected in the
UA suction bottle could also be sent for
histopathological analysis, although such tissue showed
greater anatomical distortion compared to tissue
obtained through conventional methods, particularly in
glial neoplasms and medulloblastoma.15

larger sized blood vessels for which conventional
diathermy/haemostat agents are employed. 9 This
however may not be a limitation in the latest, advanced
models. In a case control study of 40 patients, Tuncer et
al., compared the operating time of patients in whom
UA was used to those cases where UA was not
employed.19 They reported longer duration of surgery
with UA usage, and cited lack of adequate training of
neurosurgeons as the likely cause, recommending
appropriate training of staff and subsequent studies to
assess the effect.19

Lately, CUSA has also been utilized in the resection of
spinal tumours with favourable results. Chou et al.,
published a retrospective case series of paediatric
spinal cord tumours operated at their centre over a tenyear period. Seventy-five children with spinal tumours,
both intradural and extradural, were included and CUSA
was employed for tumour resection along with
conventional method. They reported gross total
resection in 45% patients, and 91% patients were
ambulatory at 3 months after surgery compared to 75%
before surgery. 16 Barzilai et al. performed a
retrospective review of 6 patients who had undergone
resection of intramedullary spinal cord tumours using
tip of the UA for intra-operative neurological
monitoring. They reported favourable outcomes and
recommended that fusing UA and electrophysiological
monitoring probe improves safety along with better
tumour resection.17

2.

There are also negative reports of UA usage.
Ridderheim et al., reported a case of vestibular
schwannoma, where the use of CUSA intra-operatively
was associated with some cases of post-operative
seventh cranial nerve palsy, which could likely be due
to transmission of strong ultrasonic waves through
petrous temporal bone.18 Another important limitation
includes the inability of CUSA to resect calcified,
fibrous and firm consistency lesions, and to coagulate

Conclusion
Although no randomised control trials have been
conducted, there is sufficient evidence in literature to
support the use of UA in brain tumour resection, and
though there are only few smaller case series on its use in
spinal tumours, no negative features have been reported.
It allows safe tumour resection, and thus improves
surgical outcome.
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